[Non-antibiotic treatments for community-acquired pneumonia in children].

Arch Pediatr

Service de médecine infantile, CHU Timone-Enfants, Marseille, France.

Published: May 1999

Besides antibiotic therapy (when warranted), treatment of acute pneumonia in children usually requires only simple measures, including: fractionated feeding, analgesic and antipyretic medications and detection of hypoxemia. There is no evidence that physical chest therapy, bronchial mucus modificators and corticosteroid therapy are really useful. The best prevention relies upon vaccinations, suppression of passive smoking, and hygiene and nutritional improvements.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0929-693x(97)83492-6DOI Listing

Publication Analysis

Top Keywords

[non-antibiotic treatments
4
treatments community-acquired
4
community-acquired pneumonia
4
pneumonia children]
4
children] antibiotic
4
antibiotic therapy
4
therapy warranted
4
warranted treatment
4
treatment acute
4
acute pneumonia
4

Similar Publications

Understanding pollutant-driven shifts of antibiotic resistome in activated sludge: A lab-scale study.

J Hazard Mater

January 2025

State Key Laboratory of Pollution Control and Resource Reuse, School of Environment, Nanjing University, Nanjing 210023, China. Electronic address:

Non-antibiotic pollutants have been identified as contributors to the development of antibiotic resistance across various environments. Wastewater treatment plants, recognized as hotspots for antibiotic resistance genes (ARGs), have received extensive attention regarding the mechanisms driving resistance changes in activated sludge. However, the specific impacts of heavy metals and aromatic organics-common pollutants in industrial wastewater-on the resistome of activated sludge, as well as the underlying mechanisms driving these effects, remain underexplored.

View Article and Find Full Text PDF

Study Design: Retrospective review.

Objectives: While most individuals with spinal cord injury (SCI) are expected to have 1-2 urinary tract infections (UTIs) per year, there is a subset with higher incidence. We evaluate our practice to characterize common causes of recurrent UTIs, hypothesizing that more frequent infections typically have addressable risk factors.

View Article and Find Full Text PDF

Validity and Utility of a Risk Prediction Model for Wound Infection After Lower Third Molar Surgery.

Oral Dis

January 2025

Laboratory of Clinical Pharmaceutics & Therapeutics, Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.

Objectives: To externally validate a clinical prediction model for surgical site infection (SSI) after lower third molar (L3M) surgery and evaluate its clinical usefulness.

Methods: We conducted a retrospective cohort study of patients who underwent L3M surgery at Hokkaido University Hospital. The study was designed to evaluate the historical and methodological transportability.

View Article and Find Full Text PDF

Antimicrobial resistance poses a significant global health threat, partly due to the overprescription of antibiotics. Understanding prescribers' behaviors and identifying knowledge gaps and misconceptions are essential for addressing antibiotic misuse and inappropriate use. Through online questionnaires, this study surveyed key stakeholders in outpatient antibiotic use in Germany (DE) and Poland (PL), including patients, physicians, and pharmacists.

View Article and Find Full Text PDF

Unveiling soil-borne antibiotic resistome and their associated risks: A comparative study of antibiotic and non-antibiotic pharmaceutical factories.

J Hazard Mater

January 2025

Key Laboratory of Recycling and Eco-Treatment of Waste Biomass of Zhejiang Province, School of Environmental and Natural Resource, Zhejiang University of Science and Technology, Hangzhou, Zhejiang 310023, China.

Antibiotic resistance genes (ARGs) and antibiotic-resistant bacteria (ARB) are extensively documented within antibiotic pharmaceutical factories. Notably, non-antibiotic pharmaceuticals also represent a significant portion of the pharmaceuticals market. However, the comparative analyses of soil-borne ARG profiles and associated risks in different categories of pharmaceutical factories remain limited.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!